header-logo header-logo

23 September 2016
Issue: 7715 / Categories: Case law , Law digest , In Court
printer mail-detail

EU

Sun Pharmaceuticals Industries Ltd and another company v European Commission T-460/13, [2016] All ER (D) 52 (Sep)

The General Court of the European Union dismissed the application by Sun Pharmaceuticals Industries Ltd (formerly Ranbaxy Laboratories Ltd) and Ranbaxy (UK) Ltd for annulment in part of Commission Decision C(2013) 3803 final of 19 June 2013 relating to a proceeding under Art 101 of the Treaty on the Functioning of the European Union and Art 53 of the European Economic Area Agreement and for reduction of the amount of the fine imposed on those companies by that decision. The General Court held that none of the pleas in law relied on by them in support of their application was well founded.

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Jurit—Nicole Gallop Mildon

Jurit—Nicole Gallop Mildon

Jurit appoints rare dual-qualified lawyer to expand Anglo-French private wealth expertise

DAC Beachcroft—Kirstie Pike & Simy Khanna

DAC Beachcroft—Kirstie Pike & Simy Khanna

DAC Beachcroft further builds national Professional Liability practice, hiring two partners in Bristol

NEWS
A child’s views can be taken into account during international child abduction proceedings, the Supreme Court has held
Small and medium-sized law firms have urged regulators to pause plans to exclude owner-managers from compliance officer roles
Lawyers have raised the alarm on employment tribunal delays and backlogs, with some cases facing a three-year wait for a hearing
The controversial assisted dying Bill has drawn to a halt after MPs defeated it by 286 votes to 270
MPs have called for legislation to protect against the human rights risks of artificial intelligence (AI)
back-to-top-scroll